Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073269 | SCV001238805 | likely pathogenic | Retinal dystrophy | 2018-09-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003558648 | SCV004282127 | pathogenic | not provided | 2023-07-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser351*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 865781). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005012534 | SCV005632205 | likely pathogenic | Autosomal dominant nonsyndromic hearing loss 11; Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1 | 2024-06-07 | criteria provided, single submitter | clinical testing |